Newsroom

Industry News

8 Nov

Willie’s Reserve Engages Jerrick Media as Digital Strategist

ENGLEWOOD, New Jersey, Nov. 8, 2016 /PRNewswire/ — Jerrick Media Holdings, Inc., (JMDA) (the “Company” or “Jerrick Media”) a digital media and technology company focused on the development and marketing of branded digital content and e-commerce properties, announced today an engagement with lifestyle brand Willie’s Reserve. Willie’s Reserve is...

Read more

7 Nov

PixarBio Corporation, Expands the NeuroRelease Leadership Team Appoints Barry Belfer, Senior Vice President of Finance

CAMBRIDGE, Mass.–(BUSINESS WIRE)— PixarBio Corporation, (OTC:PXRB) inventors of NeuroRelease™, a novel morphine replacement, non-opiate/opioid, non-addictive pain treatment, today announced the appointment of industry veteran, Barry Belfer MBA, as Senior Vice President of Finance reporting to CEO/CFO, Frank Reynolds. “PixarBio began trading last week on the OTC Markets under stock...

Read more

7 Nov

Cellectar Biosciences to Host Conference Call on November 11 to Report Third Quarter 2016 Financial Results and Corporate Performance

MADISON, Wis., Nov. 07, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (CLRB), (the “company”), an oncology-focused, clinical stage biotechnology company, today announces that management will host a teleconference and live webcast to report third quarter 2016 financial results followed by a review of corporate performance, on November 11, 2016...

Read more

7 Nov

PixarBio Corporation Closed Placement Offering Totaling $23.4MM Plus a $10MM Line of Credit to Fund the Advancement of NeuroRelease™

CAMBRIDGE, Mass.–(BUSINESS WIRE)— PixarBio Corporation, (OTC:PXRB) inventors of NeuroRelease™, a novel morphine replacement, non-opiate/opioid, non-addictive pain treatment, today announced that it has completed the closing of the sale of common shares and warrants in a private placement transaction (“the Offering”) resulting in expected proceeds of approximately $23.4 million from...

Read more

4 Nov

Cytori to Present Data in Two Distinct Models of Impaired Wound Healing

SAN DIEGO–(BUSINESS WIRE)— Cytori Therapeutics, Inc. (CYTX) will present new preclinical data describing positive effects of Cytori Cell Therapy™ on a corneal wound healing model and in cutaneous scarring following burn injury. The data will be presented at the International Federation for Adipose Therapeutics (IFATS) in San Diego on November 17-20,...

Read more

4 Nov

Onconova Announces Presentations Related to Rigosertib Clinical Studies in Myelodysplastic Syndromes at the 2016 ASH Annual Meeting

NEWTOWN, Pa., Nov. 04, 2016 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (ONTX), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that three abstracts relating to the Company’s lead product candidate, rigosertib were accepted for presentation at the 58th American...

Read more

4 Nov

Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences

PLYMOUTH MEETING, Pa., Nov. 04, 2016 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) today announced that the Company will participate at the following upcoming investment conferences: Global Mizuho Investor Conference (MIC) One-on-one meetings only Dr. Niranjan Sardesai, COO November 14, 2016 Omni Berkshire Place, New York, NY Stifel 2016...

Read more

Page 30 of 222« First...1020...2829303132...405060...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address